Intertumoral Heterogeneity within Medulloblastoma Subgroups

Cavalli, Florence M.G., Remke, Marc, Rampasek, Ladislav, Peacock, John, Shih, David J.H., Luu, Betty, Garzia, Livia, Torchia, Jonathon +87 more·2017·Cancer Cell

Cited by (1,000)

Items 801–900 of 1,000

  1. Tumorsphere Formation Assay: A Cancer Stem-Like Cell Characterization in Pediatric Brain Cancer Medulloblastoma
    Sutapa Ray · 2023 · Methods in molecular biology
  2. Copy number variation heterogeneity reveals biological inconsistency in hierarchical cancer classifications
    Ziying Yang, Paula Carrio-Cordo, Michael Baudis · 2024 · Molecular Cytogenetics
  3. MAP4 kinase-regulated reduced CLSTN1 expression in medulloblastoma is associated with increased invasiveness
    Ece Sönmez, Shen Yan, Meng-Syuan Lin, Martin Baumgartner · 2025 · Scientific Reports
  4. SUFU: The Jekyll and Hyde of the Cerebellum
    Leo J.Y. Kim, Shruti Bhargava, Ryan C. Gimple, Jeremy N. Rich · 2019 · Developmental Cell
  5. Sonic Hedgehog−Activated Large Cell/Anaplastic Medulloblastoma with Myogenic Differentiation
    Shilpa J. Rao, Alok Mohan Uppar, Vani Santosh · 2019 · World Neurosurgery
  6. A systematic view of pediatric medulloblastoma proteomics—current state of the field and future directions
    Riccardo Serra, Antonella Mangraviti · 2021 · Child s Nervous System
  7. Patient Similarity Network of Multiple Myeloma Identifies Patient Subgroups with Distinct Genetic and Clinical Features
    Sherry Bhalla · 2020 · 62nd ASH Annual Meeting and Exposition
  8. Topoisomerase IIβ immunoreactivity (IR) co-localizes with neuronal marker-IR but not glial fibrillary acidic protein-IR in GLI3-positive medulloblastomas: an immunohistochemical analysis of 124 medulloblastomas from the Japan Children’s Cancer Group
    Hiroaki Miyahara, Manabu Natsumeda, Yonehiro Kanemura, Kai Yamasaki, Yuichi Riku, Akio Akagi, Wataru Oohashi, Tomoko Shofuda, Ema Yoshioka, Yuya Sato et al. · 2021 · Brain Tumor Pathology
  9. NK cells in brain tumors: From biology to treatment
    Jawad Fares, Sumit Kumar Gupta, Vidya Gopalakrishnan, Soumen Khatua · 2021 · Elsevier eBooks
  10. Integrated computational analyses reveal novel insights into the stromal microenvironment of SHH-subtype medulloblastoma
    Alexander Landry, Nardin Samuel, Julian Spears, Zsolt E. Zador · 2021 · Scientific Reports
  11. Clinical Prognostic Implications of Wnt Hub Genes Expression in Medulloblastoma
    Andrea Martins-da-Silva, Mirella Baroni, Karina Bezerra Salomão, Pablo Shimaoka Chagas, Ricardo Bonfim-Silva, Lenisa Geron, Gustavo Alencastro Veiga Cruzeiro, Wilson A. Silva, Carolina Alves Pereira Corrêa, Carlos Gilberto Carlotti et al. · 2022 · Cellular and Molecular Neurobiology
  12. A gene dosage‐dependent effect unveils NBS1 as both a haploinsufficient tumour suppressor and an essential gene for SHH‐medulloblastoma
    Marialaura Petroni, Francesca Fabretti, Stefano Di Giulio, Vittoria Nicolis di Robilant, Veronica La Monica, Marta Moretti, Francesca Belardinilli, Francesca Bufalieri, Anna Coppa, Paola Paci et al. · 2022 · Neuropathology and Applied Neurobiology
  13. Molecular genetics of paediatric brain tumours and opportunities for precision medicine – a focus on infant tumours
    Tom Rosenberg, Pratiti Bandopadhayay · 2022 · Current Opinion in Neurology
  14. The pan-cancer landscape of abnormal DNA methylation and intratumor microorganisms
    Ping Zhou, Simon Liang Lu, Liang Chang, Baoying Liao, Ming Liang Cheng, Xiaolin Xu, Xin Sui, Fen-Ting Liu, Mingshu Zhang, Yinxue Wang et al. · 2023 · Neoplasia
  15. Medulloblastoma and Cowden Syndrome: Further Evidence of an Association
    Steffen Albrecht, Barbara Miedzybrodzki, Laura Palma, Văn Hùng Nguyễn, Roy Dudley, Torsten Pietsch, Tobias Goschzik, Nada Jabado, Catherine Goudie, William David Foulkes · 2021 · Free Neuropathology
  16. Insights into the molecular roles of FOXR2 in the pathology of primary pediatric brain tumors
    Rajendra Gharbaran · 2023 · Critical Reviews in Oncology/Hematology
  17. Embryonal Tumors of the Central Nervous System: The WHO 2016 Classification and New Insights
    Jorge Pinheiro, João Carlos Almeida, José Manuel Lopes · 2020 · Journal of Pediatric Hematology/Oncology
  18. Mechanisms of telomere maintenance in pediatric brain tumors: Promising targets for therapy – A narrative review
    Felice Giangaspero, Simone Minasi, Francesca Gianno, Hiba Alzoubi, Manila Antonelli, Francesca Romana Buttarelli · 2020 · Glioma
  19. Role of liquid biopsy in central nervous system tumors
    Rituparna Chakraborty, Vaishali S. Suri, Iman Dandapath, Jyotsna Singh, MC Sharma, Chitra Sarkar · 2021 · International Journal of Neurooncology
  20. CAR-T cells for pediatric brain tumors: Present and future
    Amaury Leruste, Kévin Beccaria, François Doz · 2021 · Bulletin du Cancer
  21. Interrogating molecular data for medulloblastoma risk stratification
    Elisabetta Ferretti, Agnese Pò · 2018 · The Lancet Oncology
  22. Expression and clinical importance of a newly discovered alternative splice variant of the gene for acrosin binding protein found in human brain tumors
    Baolong Zheng · 2020 · Asian Biomedicine
  23. Medulloblastoma
    Asifur Rahman · 2018 · InTech eBooks
  24. MRI-based prediction of molecular subgrouping in medulloblastoma: images speak louder than words
    Archya Dasgupta, Tejpal Gupta · 2019 · Oncotarget
  25. Neuro-oncology in adolescents and young adults—an unmet need
    Julie Bennett, Éric Bouffet · 2020 · Neuro-Oncology
  26. Targeting OLIG2 increases therapeutic responses in SHH medulloblastoma mouse models and patient-derived medulloblastoma organoids
    Yu-Chen Li, Taylor Dismuke, Chaemin Lim, Zara C. Bruce, Carolin Offenhäuser, U. Baumgartner, Mellissa Maybury, Rochelle C. J. D'Souza, T. Hassall, B. Wainwright et al. · 2022 · bioRxiv
  27. Lack of evidence for the transitional cerebellar progenitor
    Kyle S. Smith, Yiran Li, Parthiv Haldipur, Brian L. Gudenas, Kathleen J. Millen, Volker Hovestadt, Paul A. Northcott · 2025 · Nature
  28. Daily management of gliomas, glioneuronal, and neuronal tumors in the era of the 2021 WHO classification of nervous tumors
    Mona Mlika, Moncef Mokni, Faouzi El Mezni, Soumeya Rammeh · 2024 · Frontiers in Neurology
  29. NRF2 activation is required for chemotherapy resistance acquisition in medulloblastoma via metabolic and redox adaptation
    Lorenzo Manfreda, Fatlum Rruga, Arianna Zanolli, Bryan P. Marzullo, Lisa A. Vettore, Martina Canton, Martina Canton, Chiara Marchioro, Elena Mariotto, Elena Mariotto et al. · 2026 · Redox Biology
  30. Treatment Outcomes and Prognostic Factors for Patients With Medulloblastoma Having Defined Molecular Subtypes
    Xuejiao Shi, Shuang Liu, Xiaoyang Sun, Yiyuan Li, Mawei Jiang · 2025 · Advances in Radiation Oncology
  31. Molecular subtypes, prognostic factors, and treatment optimization in pediatric medulloblastoma: a real-world study from China
    Jingjing Liu, Yanling Sun, Huming Li, Shuxu Du, Jin Zhang, Zhen Zhang, Liming Sun, Wanshui Wu · 2025 · Frontiers in Oncology
  32. Genome-wide cfDNA fragmentation patterns in cerebrospinal fluid reflect medulloblastoma groups
    Alexander L Markowitz, Chetan Munugula, Eirini Christodoulou, Jianling Ji, Liya Xu, Jennifer A. Cotter, Venkata D. Yellapantula · 2025 · npj Precision Oncology
  33. Outcomes of Infant Medulloblastoma Treated With Standard‐Dose Chemotherapy—A Single‐Institution Experience From a Low‐Middle‐Income Country
    Gnanamani Senguttuvan, Leenu Lizbeth Joseph, Rikki Rorima John, Geeta Chacko, Ranjani Jayachandran, Krishna Prabhu, Ranjith K. Moorthy, Baylis Vivek Joseph, Rajesh Balakrishnan, Patricia Sebastian et al. · 2025 · Pediatric Blood & Cancer
  34. Neuropsychological late effects in young children with medulloblastoma: A longitudinal analysis after 5 and 15 years from the HIT-SKK-’87/’92 studies
    Holger Ottensmeier, Matthias K. Eyrich, René Schmidt, Paul‐Gerhardt Schlegel, Bernhard Zimolong, Stefanie Frahsek, Andreas Faldum, Martin Mynarek, Lisa Bußenius, Katja von Hoff et al. · 2025 · Neuro-Oncology Practice
  35. Development of a novel 4-protein signature for prognostic prediction in hepatitis B virus-induced hepatocellular carcinoma
    Haifeng Xie, Yuhong Zhao, Xianzhong Luo, Heran Zhou, Pengcheng Tong · 2025 · Discover Oncology
  36. The MYC-dependent lncRNA MB3 inhibits apoptosis in Group 3 Medulloblastoma by regulating the TGF-β pathway via HMGN5
    Alessia Grandioso, Paolo Tollis, Francesca Romana Pellegrini, Elisabetta Falvo, Alessandro Palma, Francesco Migliaccio, Alessandro Belvedere, Jessica N. Rea, Giada Tisci, Annamaria Carissimo et al. · 2025 · Cell Death and Disease
  37. Male-biased Yap1-Cd276/B7-H3 axis for immune evasion in medulloblastoma
    Nourhan Abdelfattah, Sivaraman Natarajan, Han Nhat Tran, Thomas K. S. Wong, Maryam Faisal, Jose Maldonado, Rachael A. McMinimy, Hannah Borland, Shu‐Hsia Chen, Hong Zhao et al. · 2026 · Cancer Cell
  38. Medulloblastoma in Adolescents and Young Adults: Molecular Subgroups, Prognostic Biomarkers, and Age-Specific Therapeutic Challenges
    Antonio Ruggiero, Marco Gessi, Antonio d’Amati, Alessio Albanese, Giorgio Attinà · 2026 · Current Issues in Molecular Biology
  39. Patient-derived pediatric brain tumor orthotopic xenografts and tumor organoids faithfully recapitulate primary tumors
    Justin Stephen Williams, Dana M. Farmer, Qianqian Li, Jake D. Friske, Jose A. Grenet, Sarah Robinson, Kimberly Mercer, Vanshita Goel, Laura J. Janke, Liusheng He et al. · 2026 · Science Advances
  40. Protein phosphatase 2A regulates senescence and immunogenicity in medulloblastoma models
    Winson S. Ho, Isha Mondal, Jingjing Liu, Raymond Sun, Jiawei Huo, Chao Gao, Oishika Das, Daren Tieu, Jingqi Sun, Hanchen Lin et al. · 2026 · Journal of Clinical Investigation
  41. Pediatric metastatic medulloblastoma: upfront biopsy followed by oncological treatment without excision of the primary tumor
    Rina Dvir, Ronit Elhasid, Jonathan Roth, Shlomi Constantini, Yair Peled, Inna Ospovat, Shelly Irene Shiran · 2026 · Journal of Neurosurgery Pediatrics
  42. Advances in targeted therapies for pediatric tumors
    Jia-yi Liu, Dong-liang Yang, Hai-yan Liu, Sen-feng Xiang, Ji Cao, Bo Yang, Qiao-Jun He, Jinhu Wang, Xue‐jing Shao, Mei-dan Ying · 2026 · Acta Pharmacologica Sinica
  43. Subgroup-Specific Associations of GRIA Genes Encoding AMPA Glutamate Receptor Subunits with Patient Survival in Medulloblastoma
    Bruno Saciloto, Matheus Dalmolin, Júlia Caroline Marcolin, Martina Lichtenfels, Júlia Vanini, Isabella B. Schroder Roesler, Jurandir M. Ribas Filho, Osvaldo Malafaia, Marcelo A.C. Fernandes, Caroline Brunetto de Farias et al. · 2026 · NeuroMolecular Medicine
  44. Neuroimaging of Brain Tumors in the Era of Radiogenomics
    Prem Pradeep Batchala, Thomas Jose Eluvathingal Muttikkal, Joseph Donahue, M. Beatriz S. Lopes, Eli S. Williams, Nicholas James Tustison, Sohil Harshad Patel · 2023 · Springer eBooks
  45. Modulation of Viability, Proliferation, and Stemness by Rosmarinic Acid in Medulloblastoma Cells: Involvement of HDACs and EGFR
    Alice Laschuk Herlinger, Gustavo Lovatto Michaelsen, Marialva Sinigaglia, Lívia Fratini, Gabriela Nogueira Debom, Elizandra Braganhol, Caroline Brunetto de Farias, Algemir Lunardi Brunetto, Andre Tesainer Brunetto, Mariane da Cunha Jaeger et al. · 2023 · NeuroMolecular Medicine
  46. Survival-Related Genes on Chromosomes 6 and 17 in Medulloblastoma
    Jerry P. Vriend, Xiaoqing Liu · 2024 · International Journal of Molecular Sciences
  47. Racial distribution of molecularly classified brain tumors
    Camila S. Fang, Wanyi Wang, Chanel Schroff, Misha Movahed-Ezazi, Varshini Vasudevaraja, Jonathan Serrano, Erik P. Sulman, John G. Golfinos, Daniel A. Orringer, Kristyn Galbraith et al. · 2024 · Neuro-Oncology Advances
  48. In-depth inference of transcriptional regulatory networks reveals NPM1 as a therapeutic ribosomal regulator in MYC-amplified medulloblastoma
    Tong Chen, Huiyao Chen, Mingyang Xia, Yunfei Liao, Hao Li, Xinran Dong, Yifeng Lin, Wenhao Zhou · 2025 · npj Precision Oncology
  49. Transcription of Clock Genes in Medulloblastoma
    Jerry P. Vriend, Aleksandra Głogowska · 2025 · Cancers
  50. Central Nervous System Tumor Classification
    Roger E. McLendon, Anthony T. Yachnis, C. Ryan Miller, Ho‐Keung Ng · 2021 · Hematology/Oncology Clinics of North America
  51. Molecular and clinical correlates of medulloblastoma subgroups
    Hallie Coltin, Vijay Ramaswamy · 2021 · Glioma
  52. Progress and possibilities for patient-derived iPSCs and genetically engineered stem cells in cancer modeling and targeted therapies
    Lon Kai Pang, Mo-Fan Huang, Julian A. Gingold, Mezthly Pena, Ruiying Zhao, Dung‐Fang Lee · 2022 · Elsevier eBooks
  53. Network Approaches for Precision Oncology
    Shraddha Pai · 2022 · Advances in experimental medicine and biology
  54. Medulloblastoma and the DNA Damage Response
    Leon McSwain, Kiran K. Parwani, Shubin Shahab, Dolores Hambardzumyan, Tobey J. MacDonald, Jennifer M. Spangle, Anna Marie Kenney · 2022 · Frontiers in Oncology
  55. Updated classification of tumors of the central nervous system as the basis for individual patient therapy
    A. A. Zrelov, N. E. Nechaeva, N. E. Voinov · 2022 · Russian Journal for Personalized Medicine
  56. Case report: Somatic mutations in microtubule dynamics-associated genes in patients with WNT-medulloblastoma tumors
    Rostislav K. Skitchenko, Yu. V. Dinikina, Sergey Smirnov, Mikhail Krapivin, А. Yu. Smirnova, D. A. Morgacheva, Mykyta Artomov · 2023 · Frontiers in Oncology
  57. The phosphorylation of PHF5A by TrkA-ERK1/2-ABL1 cascade regulates centrosome separation
    Chen Song, Yu Zhang, Yutong Li, Juntao Bie, Zhe Wang, Xin Ping Yang, Haishuang Li, Liangyi Zhu, Tianzhuo Zhang, Qing Chang et al. · 2023 · Cell Death and Disease
  58. Timing is everything: A connection between medulloblastoma prognosis and foetal cerebellar development
    Daniel Williamson, Ed C. Schwalbe, Simon Bailey, Steven C. Clifford · 2023 · Neuropathology and Applied Neurobiology
  59. Deriving a continuum score for group 3 and 4 medulloblastoma tumor samples analyzed via RNA-sequencing or DNA methylation microarray
    James Hacking, Dean Thompson, Ed C. Schwalbe, Steven C. Clifford, Daniel Williamson · 2023 · STAR Protocols
  60. EpiGe: A machine-learning strategy for rapid classification of medulloblastoma using PCR-based methyl-genotyping
    Soledad Gómez‐González, J. Andres De Llano, Marta Garcia, Alícia Garrido-Garcia, Mariona Suñol, Isadora Versiani de Lemos, Sara Pérez‐Jaume, Noelia Salvador, Nagore Gené Olaciregui, Raquel Arnau et al. · 2023 · iScience
  61. Treatment response as surrogate to predict risk for disease progression in pediatric medulloblastoma with persistent magnetic resonance imaging lesions after first-line treatment
    Denise Obrecht, Lena Schömig, Martin Mynarek, Brigitte Bison, Rudolf Schwarz, Torsten Pietsch, Stefan Michael Pfister, Martin Sill, Dominik Sturm, Felix Sahm et al. · 2024 · Neuro-Oncology
  62. Characterization of immune microenvironment associated with medulloblastoma metastasis based on explainable machine learning
    Fengmao Zhao, Xiangjun Liu, Jingang Gui, Hailang Sun, Nan Zhang, Yun Peng, Ming Ge, Wei Wang · 2025 · Pediatric Investigation
  63. High-resolution proteomic analysis of medulloblastoma clinical samples identifies therapy-resistant subgroups and MYC immunohistochemistry as a powerful outcome predictor
    Alberto Delaidelli, Fares Burwag, Susana Ben‐Neriah, Yujin Suk, Taras Shyp, Suzanne Kosteniuk, Christopher P. Dunham, Sylvia S. Cheng, Konstantin Okonechnikov, Daniel Schrimpf et al. · 2025 · Neuro-Oncology
  64. The intersections between neuroscience and medulloblastoma
    Yafei Wang, Ying Yu, Jiahua Yu, Cheng Wang, Yunkun Wang, Runxi Fu, Chenran Zhang · 2025 · Cancer Letters
  65. Adult Medulloblastoma: Clinicomolecular Spectrum, An Institutional Experience
    Vishesha Adhvaryu, Mamta Gurav, Gauri Deshpande, Rachana Rumde, Omshree Anil Shetty, Ayushi Sahay, Arpita Sahu, Archya Dasgupta, Abhishek Chatterji, Tejpal Gupta et al. · 2025 · International Journal of Surgical Pathology
  66. Medulloblastoma associated with Lynch syndrome: a case report of germline MLH1 variant and tumor molecular characterization
    Han Zheng, Gang Zhang, Bin Jiang, Luyi Zhang, Qianqian Duan, Hangyu Shi · 2025 · Investigational New Drugs
  67. The role of DNA methylation in directing treatment in medulloblastoma
    Mohammed A H Alsaedi, Gordon R. Strathdee · 2025 · Epigenomics
  68. Integrated clinical and molecular landscape of disseminated pediatric low-grade glioma
    Adrian Levine, Julie Bennett, Prabhumallikarjun Patil, Ian Burns, Robert Siddaway, Cyril Li, Joseline Haizel‐Cobbina, Mansuba Rana, Richard Yuditskiy, Andrew Son et al. · 2025 · Neuro-Oncology
  69. Diagnosis and management of central nervous system embryonal tumors in the molecular era
    Vani Santosh, Shilpa J. Rao, Archya Dasgupta, Tejpal Gupta · 2021 · International Journal of Neurooncology
  70. Imaging Embryonal Tumors of the Central Nervous System
    Zoltan J Patay · 2022 · Advances in Clinical Radiology
  71. Expression pattern of MRPS18 family genes in medulloblastoma: a case report
    Larysa M. Kovalevska, В.М. Щербіна, Serhii S. Kalman, L. M. Verbova, В. Д. Розуменко, Т. А. Малышева, Elena Kashuba · 2022 · Ukrainian Neurosurgical Journal
  72. Case report of a pediatric medulloblastoma with concurrent MYC and MYCN subclonal amplification in distinct populations of neoplastic cells
    Simone Minasi, Francesca Gianno, Lavinia Bargiacchi, Valeria Barresi, Evelina Miele, Manila Antonelli, Francesca Romana Buttarelli · 2023 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  73. Are molecular subgroups of medulloblastomas really prognostic?
    Didier Frappaz, Cécile Faure‐Conter, David Meyronet, Alice Bonneville-Levard, Pierre-Aurélien Beuriat, Marie Pierre Sunyach, Marc Barritault · 2018 · Current Opinion in Neurology
  74. Prognostic value of molecular, genetic and clinical characteristics of SHH group medulloblastoma
    Ludmila I. Papusha, Alexander E. Druy, Liudmila A. Yasko, Z. S. Supik, Л. В. Земцова, А. П. Эктова, Д. М. Коновалов, Kirill A. Voronin, А. А. Merishavyan, И. Д. Бородина et al. · 2018 · Pediatric Hematology/Oncology and Immunopathology
  75. Histopathologic and Molecular Features of Central Nervous System Embryonal Tumors for Integrated Diagnosis Reporting
    Bonnie Cole, Christopher R. Pierson · 2020 · Surgical pathology clinics
  76. Challenges and Recent Advances of Novel Chemical Inhibitors in Medulloblastoma Therapy
    Anand Maurya, Upendra Kumar Patel, Jitendra Kumar Yadav, Virender Pratap Singh, Alka Agarwal · 2022 · Methods in molecular biology
  77. The Molecular Landscape of Medulloblastoma in Teenagers and Young Adults
    Omar J. Mohammed, Maria Estevez Cebrero, Omar Ahmad, Andrew C. Peet, Richard Guy Grundy, Anbarasu Lourdusamy · 2022 · Cancers
  78. Applications of noncoding RNAs in brain cancer patients
    Małgorzata Grabowska, Julia Oliwia Misiorek, Żaneta Zarębska, Katarzyna Rolle · 2022 · Elsevier eBooks
  79. Chromosomal Instability Characterizes Pediatric Medulloblastoma but Is Not Tolerated in the Developing Cerebellum
    Irena Bočkaj, Tosca E. I. Martini, Marlinde J. Smit, Inna Armandari, Björn Bakker, René Wardenaar, Tiny Meeuwsen-de Boer, Petra L. Bakker, Diana C.J. Spierings, Eelco Wieger Hoving et al. · 2022 · International Journal of Molecular Sciences
  80. Inhibition of the amino-acid transporter LAT1 demonstrates anti-neoplastic activity in medulloblastoma
    Yann Cormerais, Marina Pagnuzzi-Boncompagni, Sandra Schrötter, Sandy Giuliano, Eric Tambutté, Hitoshi Endou, Michael F. Wempe, Gilles Pagès, Jacques Pouysségur, Vincent Picco · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  81. Super-sonic speed of DNA synthesis in medulloblastoma
    Apolinar Maya‐Mendoza, Jiří Bártek · 2020 · Nature Cancer
  82. Medulloblastoma (cross)talk through extracellular vesicles
    Liana Figueiredo Nobre, Vijay Ramaswamy · 2021 · Neuro-Oncology
  83. Dissecting adult SHH-activated medulloblastoma—molecularly defined tumor subsets reveal new prognostic biomarkers
    Peter Hau · 2021 · Neuro-Oncology
  84. Modelling medulloblastoma pathogenesis and treatment in human cerebellar organoids
    Thomas Willott, James G Nicholson, Yunchen Xiao, Olumide Kayode Ogunbiyi, Benjamin Draper, Talisa Mistry, Laura Donovan, Nicolae Radu Zabet, Ashirwad Merve, Sara Badodi et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  85. Ezh2 Delays Activation of Differentiation Genes During Normal Cerebellar Granule Neuron Development and in Medulloblastoma
    James Purzner, Alexander S. Brown, Teresa Purzner, Lauren Ellis, Sara Broski, Ulrike M. Litzenburger, Kaytlin Andrews, Aryaman Sharma, Xin Wang, Michael D. Taylor et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  86. Aberrant FGF signaling promotes granule neuron precursor expansion in SHH subgroup infantile medulloblastoma
    Odessa Yabut, Jessica Chelsea Arela, Hector G. Gomez, Jesse Garcia Castillo, Thomas T. Ngo, Samuel J. Pleasure · 2024 · eLife
  87. Ezh2 Delays Activation of Differentiation Genes During Normal Cerebellar Granule Neuron Development and in Medulloblastoma
    James Purzner, Alexander S. Brown, Teresa Purzner, Lauren Ellis, Sara Broski, Ulrike M. Litzenburger, Kaytlin Andrews, Aryaman Sharma, Xin Wang, Michael D. Taylor et al. · 2025 · eLife
  88. Modeling medulloblastoma pathogenesis and treatment in human cerebellar organoids
    Thomas Willott, James G. Nicholson, Xinyu Zhang, Yunchen Xiao, Olumide Kayode Ogunbiyi, Benjamin Draper, Talisa Mistry, Laura Donovan, Ashirwad Merve, Nicolae Radu Zabet et al. · 2026 · Genes & Development
  89. The Medulloblastoma Meta-Analysis Portal Enables Integrative Exploration of Clinical and Genomic Data from Patients
    Gangwani, Karishma, Lu, Congyu, Dhanda, Sandeep Kumar, Sioson, Edgar, Zaldívar Peraza, Airen, Matt, Gavriel Y., Paul, Robin, Wang, Jian, Reilly, Colleen, Acić, Aleksandar et al. · 2025 · Cancer Research
  90. A narrative review of what the neuropathologist needs to tell the clinician in neuro-oncology practice concerning WHO CNS5
    Yanghao Hou, Felix Sahm · 2022 · Glioma
  91. A Prognostic Methylation-Driven Two-Gene Signature in Medulloblastoma
    Gustavo Lovatto Michaelsen, Lívia Dos Reis Edinger da Silva, Douglas da Silva Lima, Mariane da Cunha Jaeger, Andre Tesainer Brunetto, Rodrigo Juliani Siqueira Dalmolin, Marialva Sinigaglia · 2024 · Journal of Molecular Neuroscience
  92. Bioinformatic Analysis of Gene Expression Related to Sialic Acid Biosynthesis in Patients With Medulloblastoma
    Mudathir S. Bakhit, Masazumi Fujii · 2024 · Cureus
  93. A Radiomic Approach for Evaluating Intra-Subgroup Heterogeneity in SHH and Group 4 Pediatric Medulloblastoma: A Preliminary Multi-Institutional Study
    Marwa Ismail, Hyemin Um, Ralph Salloum, Fauzia Hollnagel, Raheel Ahmed, Peter M K de Blank, Pallavi Tiwari · 2024 · Cancers
  94. ENTPD1 (CD39) and NT5E (CD73) expression in human medulloblastoma: an in silico analysis
    Marco Antônio Stefani, Elizandra Braganhol, Guilherme Tomasi Santos, Samuel Masao Suwa, Daiane Dias Cabeleira, Guilherme Pamplona Bueno de Andrade · 2024 · Purinergic Signalling
  95. Basic Science of Pediatric Brain Tumors
    Michael S. Taccone, Dilakshan Srikanthan, James T. Rutka, Vijay Ramaswamy · 2024 · Springer eBooks
  96. Molecular interplay between the upregulated levels of Sad1 and UNC84 Domain Containing 2 (SUN2) and gene expression in medulloblastoma cells
    Ángeles C. Tecalco-Cruz, Marina Macías‐Silva, Marcela Sosa‐Garrocho, Augusto César Poot-Hernández, Carlos Alberto Peralta‐Álvarez, Josué O. Ramírez‐Jarquín, Carlo César Cortés-González, Leslie Figueroa-Rivera, César López‐Camarillo · 2024 · Molecular Biology Reports
  97. Leveraging Random Forest Machine Learning for Subgroup Classification of Medulloblastoma
    Bo Lan · 2024 · Journal of Research in Social Science and Humanities
  98. Therapeutic approaches for targeting the pediatric brain tumor microenvironment
    Caroline A. Stockwell, Morrent Thang, David E. Kram, Andrew Satterlee, Shawn Hingtgen · 2025 · Drug Delivery and Translational Research
  99. Immunohistochemical detection of 5-hydroxymethylcytosine as a prognostic biomarker in non-WNT/Non-SHH medulloblastomas
    Han-Guang Zhao, Si-kang Ren, Wentao Zhou, Zhiming Liu, Lei‐Ming Wang, Yongji Tian, Fu Qiang Zhao · 2025 · Scientific Reports
  100. Uncovering the Understanding of the Concept of Patient Similarity in Cancer Research and Treatment: Scoping Review
    Iryna Manuilova, Jan Bossenz, Annemarie Bianka Weise, Dominik Boehm, Marvin Döbel, Silke D Werle, Arsenij Ustjanzew, Niklas Reimer, Cosima Strantz, Philipp Unberath et al. · 2025 · Journal of Medical Internet Research